Skip to content

Clinical Study on Syndrome Differentiation of TCM in Treating Severe and Critical novel coronavirus pneumonia (COVID-19)

Clinical Study on Syndrome Differentiation of TCM in Treating Severe and Critical novel coronavirus pneumonia (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030188
Enrollment
Unknown
Registered
2020-02-24
Start date
2020-02-15
Completion date
Unknown
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Sponsors

Guangdong Provincial Hospital of Chinese Medicine - Zhuhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Comply with the diagnostic criteria for COVID-19 in the "Diagnosis and Treatment Program for pneumonia caused by novel coronavirus infection (Trial Version 5)", meet the the criteria of severe and critical type; (2) Agree to participate in the study and the patient or legal guardian signs the informed consent form.

Exclusion criteria

Exclusion criteria: (1) It is difficult to administer to patients by oral or nasal feeding; (2) Pregnant women, as well as patients with other malignancies such as malignant tumors, mental illnesses, and patients who are not considered suitable for study.

Design outcomes

Primary

MeasureTime frame
TCM symptom score;Becomes negative time of COVID-19;Cure / mortality rate;

Secondary

MeasureTime frame
Major symptom relief time;Blood gas analysis;Indicators of inflammation (CRP, ESR);Chest CT;

Countries

China

Contacts

Public ContactDonghui Huang

Guangdong Provincial Hospital of Chinese Medicine - Zhuhai Hospital

13600001163@139.com+86 0756-3325892

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026